• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Sun Pharmaceutical Industries Limited — Updates, 17-11-2025: Press Release

    17-11-2025 | 04:02 pm

    Sun Pharma partnered with AstraZeneca to market Sodium Zirconium Cyclosilicate (SZC) in India for Hyperkalaemia under the brand Gimliand®. This collaboration expands access to a crucial treatment, bolstering Sun Pharma's portfolio and market presence in chronic kidney disease therapy.

    No comments yet. Be the first to comment!

    All announcements from Sun Pharmaceutical Industries Limited